Trevi Therapeutics
TRVI
#5279
Rank
A$1.99 B
Marketcap
A$15.53
Share price
-2.59%
Change (1 day)
55.98%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -A$71.52 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$68.24 Million a decrease over its 2023 earnings that were of -A$40.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$71.52 Million4.8%
2024 -A$68.24 Million67%
2023 -A$40.87 Million2.43%
2022 -A$39.9 Million-14.45%
2021 -A$46.64 Million1.36%
2020 -A$46.01 Million23.64%
2019 -A$37.22 Million27.54%
2018 -A$29.18 Million